Annual Current Assets
$201.06 M
-$45.62 M-18.49%
December 31, 2023
Summary
- As of February 7, 2025, ESPR annual total current assets is $201.06 million, with the most recent change of -$45.62 million (-18.49%) on December 31, 2023.
- During the last 3 years, ESPR annual current assets has fallen by -$144.83 million (-41.87%).
- ESPR annual current assets is now -41.87% below its all-time high of $345.90 million, reached on December 31, 2020.
Performance
ESPR Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$307.56 M
-$37.55 M-10.88%
September 30, 2024
Summary
- As of February 7, 2025, ESPR quarterly total current assets is $307.56 million, with the most recent change of -$37.55 million (-10.88%) on September 30, 2024.
- Over the past year, ESPR quarterly current assets has dropped by -$37.55 million (-10.88%).
- ESPR quarterly current assets is now -15.88% below its all-time high of $365.61 million, reached on March 31, 2024.
Performance
ESPR Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
ESPR Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.5% | -10.9% |
| 3 y3 years | -41.9% | -10.9% |
| 5 y5 years | +41.0% | +21.3% |
ESPR Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.9% | at low | -15.9% | +53.0% |
| 5 y | 5-year | -41.9% | at low | -15.9% | +80.2% |
| alltime | all time | -41.9% | >+9999.0% | -15.9% | +4208.5% |
Esperion Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $307.56 M(-10.9%) |
| Jun 2024 | - | $345.11 M(-5.6%) |
| Mar 2024 | - | $365.61 M(+81.8%) |
| Dec 2023 | $4.73 M(+276.7%) | $201.06 M(-7.9%) |
| Sep 2023 | - | $218.23 M(-6.0%) |
| Jun 2023 | - | $232.13 M(-7.4%) |
| Mar 2023 | - | $250.60 M(+1.6%) |
| Dec 2022 | $1.26 M(-97.6%) | $246.68 M(-5.8%) |
| Sep 2022 | - | $261.79 M(+3.7%) |
| Jun 2022 | - | $252.48 M(-13.2%) |
| Mar 2022 | - | $290.82 M(-11.6%) |
| Dec 2021 | $52.62 M(+614.7%) | $328.97 M(+92.8%) |
| Sep 2021 | - | $170.67 M(-38.0%) |
| Jun 2021 | - | $275.17 M(+1.0%) |
| Mar 2021 | - | $272.57 M(-21.2%) |
| Dec 2020 | $7.36 M(+169.4%) | $345.90 M(+42.5%) |
| Sep 2020 | - | $242.80 M(-24.4%) |
| Jun 2020 | - | $321.37 M(+86.2%) |
| Mar 2020 | - | $172.63 M(-18.5%) |
| Dec 2019 | $2.73 M(+233.7%) | $211.71 M(-16.5%) |
| Sep 2019 | - | $253.46 M(-17.5%) |
| Jun 2019 | - | $307.12 M(+30.6%) |
| Mar 2019 | - | $235.22 M(+64.9%) |
| Dec 2018 | $819.00 K | $142.63 M(-15.2%) |
| Sep 2018 | - | $168.21 M(-10.9%) |
| Jun 2018 | - | $188.88 M(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $201.41 M(-1.2%) |
| Dec 2017 | $73.91 M(+133.6%) | $203.92 M(-1.4%) |
| Sep 2017 | - | $206.82 M(+21.0%) |
| Jun 2017 | - | $170.95 M(-9.1%) |
| Mar 2017 | - | $188.01 M(-12.0%) |
| Dec 2016 | $31.64 M(-61.0%) | $213.58 M(+0.1%) |
| Sep 2016 | - | $213.47 M(+2.1%) |
| Jun 2016 | - | $209.09 M(+6.1%) |
| Mar 2016 | - | $197.05 M(-8.1%) |
| Dec 2015 | $81.18 M(+121.9%) | $214.39 M(-2.0%) |
| Sep 2015 | - | $218.84 M(-3.0%) |
| Jun 2015 | - | $225.71 M(-19.3%) |
| Mar 2015 | - | $279.83 M(+162.3%) |
| Dec 2014 | $36.58 M(+107.0%) | $106.70 M(+95.5%) |
| Sep 2014 | - | $54.58 M(-11.0%) |
| Jun 2014 | - | $61.32 M(+5.2%) |
| Mar 2014 | - | $58.28 M(-3.9%) |
| Dec 2013 | $17.67 M(>+9900.0%) | $60.62 M(-16.9%) |
| Sep 2013 | - | $72.96 M(+276.3%) |
| Jun 2013 | - | $19.39 M(-12.4%) |
| Mar 2013 | - | $22.12 M(+209.9%) |
| Dec 2012 | $174.00 K(-44.9%) | $7.14 M |
| Dec 2011 | $315.70 K(-94.9%) | - |
| Dec 2002 | $6.14 M(-12.9%) | - |
| Dec 2001 | $7.05 M(+7.9%) | - |
| Dec 2000 | $6.54 M(+234.2%) | - |
| Dec 1999 | $1.96 M | - |
FAQ
- What is Esperion Therapeutics annual total current assets?
- What is the all time high annual current assets for Esperion Therapeutics?
- What is Esperion Therapeutics annual current assets year-on-year change?
- What is Esperion Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly current assets year-on-year change?
What is Esperion Therapeutics annual total current assets?
The current annual current assets of ESPR is $201.06 M
What is the all time high annual current assets for Esperion Therapeutics?
Esperion Therapeutics all-time high annual total current assets is $345.90 M
What is Esperion Therapeutics annual current assets year-on-year change?
Over the past year, ESPR annual total current assets has changed by -$45.62 M (-18.49%)
What is Esperion Therapeutics quarterly total current assets?
The current quarterly current assets of ESPR is $307.56 M
What is the all time high quarterly current assets for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly total current assets is $365.61 M
What is Esperion Therapeutics quarterly current assets year-on-year change?
Over the past year, ESPR quarterly total current assets has changed by -$37.55 M (-10.88%)